Pyridazinone compounds and uses thereof
US11091464B2 · kind B2 · utility
9Cited by
2References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 3, 2020 |
| Grant date | Aug 17, 2021 |
| Priority date | — |
| Expiry date | Nov 3, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Substituted pyridazinone compounds, conjugates, and pharmaceutical compositions for use in the treatment of neuromuscular diseases, such as Duchenne Muscular Dystrophy (DMD), are disclosed herein. The disclosed compounds are useful, among other things, in the treating of DMD and modulating inflammatory inhibitors IL-1, IL-6 or TNF-α.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.